Tumor gene expression patterns affecting response to BCl-2 inhibitor venetoclax in acute myeloid leukemia

被引：0
|
作者：
Garay, Juan Antonio Raygoza
Yun, Seongseok
Osman, Afaf
Ramlal, Reshma
Feith, David
Churchman, Michelle
Dhakal, Prajwal
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5852
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5852
引用
收藏
页数：2
相关论文
共 50 条
  • [41] High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia
    Karakas, T
    Maurer, U
    Weidmann, E
    Miething, CC
    Hoelzer, D
    Bergmann, L
    ANNALS OF ONCOLOGY, 1998, 9 (02) : 159 - 165
  • [42] Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia
    Wei, Wenwen
    Huang, Shujuan
    Ling, Qing
    Mao, Shihui
    Qian, Yu
    Ye, Wenle
    Li, Fenglin
    Pan, Jiajia
    Lin, Xiangjie
    Huang, Jiansong
    Huang, Xin
    Zhai, Yifan
    Sun, Jie
    Jin, Jie
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [43] Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia
    Wenwen Wei
    Shujuan Huang
    Qing Ling
    Shihui Mao
    Yu Qian
    Wenle Ye
    Fenglin Li
    Jiajia Pan
    Xiangjie Lin
    Jiansong Huang
    Xin Huang
    Yifan Zhai
    Jie Sun
    Jie Jin
    Journal of Translational Medicine, 20
  • [44] A concise review of BCL-2 inhibition in acute myeloid leukemia
    Yogarajah, Meera
    Stone, Richard M.
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (02) : 145 - 154
  • [45] Targeting Bcl-2 in acute myeloid leukemia cells.
    Simms-Waldrip, T
    Hernandez, J
    Shankar, D
    Moore, TB
    Sakamoto, KM
    JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (01) : S105 - S105
  • [46] BCL-2 inhibitor venetoclax reduces proliferation in acute B-lymphoblastic leukemia cells in vitro and in vivo
    Holz, C.
    Richter, A.
    Lange, S.
    Sekora, A.
    Knuebel, G.
    Jeremias, I
    Vollmar, B.
    Junghanss, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 15 - 15
  • [47] BCL-2 inhibition in acute myeloid leukemia: resistance and combinations
    Tatarata, Qi Zhang
    Wang, Zhe
    Konopleva, Marina
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (12) : 935 - 946
  • [48] 225Ac-labeled CD33-targeting antibody reverses resistance to Bcl-2 inhibitor venetoclax in acute myeloid leukemia models
    Garg, Ravendra
    Allen, Kevin J. H.
    Dawicki, Wojciech
    Geoghegan, Eileen M.
    Ludwig, Dale L.
    Dadachova, Ekaterina
    CANCER MEDICINE, 2021, 10 (03): : 1128 - 1140
  • [49] THE RELATIONSHIP BETWEEN BCL-2 EXPRESSION AND RESPONSE TO CHEMOTHERAPY IN ACUTE-LEUKEMIA
    MAUNG, ZT
    MACLEAN, FR
    REID, MM
    PEARSON, ADJ
    PROCTOR, SJ
    HAMILTON, PJ
    HALL, AG
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (01) : 105 - 109
  • [50] Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
    Qi Zhang
    Bridget Riley-Gillis
    Lina Han
    Yannan Jia
    Alessia Lodi
    Haijiao Zhang
    Saravanan Ganesan
    Rongqing Pan
    Sergej N. Konoplev
    Shannon R. Sweeney
    Jeremy A. Ryan
    Yulia Jitkova
    Kenneth Dunner
    Shaun E. Grosskurth
    Priyanka Vijay
    Sujana Ghosh
    Charles Lu
    Wencai Ma
    Stephen Kurtz
    Vivian R. Ruvolo
    Helen Ma
    Connie C. Weng
    Cassandra L. Ramage
    Natalia Baran
    Ce Shi
    Tianyu Cai
    Richard Eric Davis
    Venkata L. Battula
    Yingchang Mi
    Jing Wang
    Courtney D. DiNardo
    Michael Andreeff
    Jeffery W. Tyner
    Aaron Schimmer
    Anthony Letai
    Rose Ann Padua
    Carlos E. Bueso-Ramos
    Stefano Tiziani
    Joel Leverson
    Relja Popovic
    Marina Konopleva
    Signal Transduction and Targeted Therapy, 7
12345